Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
280 Bio receives IND approval from the FDA for YL-17231 2023-07-07 20:00
Forge Stronger Partnership for Advanced ADC Development! GeneQuantum Healthcare and Aimed Bio collaborate to develop five innovative ADC drugs 2023-07-07 10:19
Hexvix®, A Diagnostic Drug for Bladder Cancer of Asieris has Completed the Phase III bridging trial Enrollment 2023-07-06 18:33
Genesis MedTech Receives Approval for Launch in China for ArtiSential™ 2023-07-06 18:00
Registrational Pivotal Phase III Study of Olverembatinib for the First-Line Treatment of Patients with Ph+ ALL Approved by the CDE in China 2023-07-06 10:38
Biosion, Inc. Appoints Furqan Ahmed, PharmD as Vice President and Head of Business Development 2023-07-05 22:05
TiumBio and Hansoh Pharma Announce Clinical Trial Approval of 'HS-10518/TU2670' from NMPA in China 2023-07-05 20:00
BGI CEO Yin Ye Advocates for Global Technology Sharing 2023-07-05 14:17
Jacobio Receives CDE Approval for Glecirasib's Pancreatic Cancer Pivotal Study in China 2023-07-04 21:16
Positive guidance from US FDA on Cu-64 SAR-bisPSMA Phase III trial in prostate cancer 2023-07-04 20:55
China NMPA approves RareStone's pitolisant (Wakix) for the treatment of narcolepsy 2023-07-04 20:42
Skyline Therapeutics Receives FDA Clearance of IND for SKG0106, a Novel Intravitreally Delivered AAV Gene Therapy Candidate for Neovascular Age-related Macular Degeneration 2023-07-03 19:00
Henlius Forecasts Profit in 1H 2023 2023-07-03 17:49
Zymedi announced their collaboration with the National Heart, Lung, and Blood Institute through a CTA CRADA to develop ZMA001 mAb, a potential treatment for Pulmonary Arterial Hypertension (PAH), a rare, female predominant disease 2023-07-03 08:00
HaemaLogiX Announces Positive Final Results from KappaMab Combination Phase IIb Myeloma Trial 2023-06-29 19:00
Clarity establishes a US Center of Excellence for Targeted Copper Theranostics 2023-06-28 20:58
Sanyou Forms Partnership with Hangzhou Zhongmei Huadong Pharmaceutical, Catalyzing Innovative Drug Research and Development 2023-06-28 20:00
LYMPHOMA THERAPY NOW APPROVED FOR AUSTRALIAN PATIENTS With Diffuse Large B-cell Lymphoma 2023-06-28 04:00
HitGen launches a newly upgraded version of OpenDEL™, a self-service screening kit, to facilitate innovative drug discovery research 2023-06-26 21:30
SK pharmteco doubles viral vector production capacity in Europe 2023-06-23 07:30
1 47 48 49 50 51 222